United States · FDA National Drug Code directory
Tamiflu
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0004-0822_94a312ac-c47a-4437-8dd3-6bcd7e08e42c
- Product NDC
- 0004-0822
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- Oseltamivir Phosphate
- Labeler
- Genentech, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20110321
- Source listing expiry
- 20261231
Source-listed ingredients
- OSELTAMIVIR PHOSPHATE — 6 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, GLASS in 1 CARTON (0004-0822-05) / 60 mL in 1 BOTTLE, GLASS · 0004-0822-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →